Literature DB >> 25697089

Evaluation of two community-controlled peer support services for assessment and treatment of hepatitis C virus infection in opioid substitution treatment clinics: The ETHOS study, Australia.

Carla Treloar1, Jake Rance1, Nicky Bath2, Hope Everingham2, Michelle Micallef3, Carolyn Day4, Sue Hazelwood5, Jason Grebely3, Gregory J Dore3.   

Abstract

AIM: Peer support services have been shown to be beneficial in increasing uptake and adherence to treatment in other areas but few examples of these services exist in hepatitis C (HCV) care. This study examined the performance of two community-controlled peer support services operating within a larger study aimed at increasing access to HCV care and treatment for opiate substitution treatment (OST) clients, ETHOS.
METHODS: Semi-structured interviews were conducted in two clinics with three groups of participants: clients (n=31), staff (n=8) and peer workers (n=3) and examined the operation of the service in relation to process, outputs and impacts.
RESULTS: There was a very strong positive response to the peer worker services reported by staff and clients who had and had not interacted with a peer worker. A number of changes were reported that were not explicit goals of the service including providing access to additional services for clients and staff, peer workers acting as mediators between clients and staff and a less tangible notion of a changing "feel" of the clinic to a more positive and client-friendly social and physical space. Explicit goals of the service were also reported in peer workers supporting clients to consider and prepare for treatment (via blood tests and other assessments) as well as provide information and support about treatment.
CONCLUSIONS: The peer support service was acceptable to clients and clinic staff. All groups of participants noted that the service met its goals of engaging clients, building trusting relationships and providing instrumental support for clients to access HCV treatment. Peer workers may also contribute to more effective deployment of health resources by preparing clients for clinical engagement with HCV health workers.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hepatitis C; Peer support; People who inject drugs; Qualitative; Treatment

Mesh:

Year:  2015        PMID: 25697089     DOI: 10.1016/j.drugpo.2015.01.005

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  22 in total

Review 1.  Integrated opioid substitution therapy and HIV care: a qualitative systematic review and synthesis of client and provider experiences.

Authors:  Andy Guise; Maureen Seguin; Gitau Mburu; Susie McLean; Pippa Grenfell; Zahed Islam; Sergii Filippovych; Happy Assan; Andrea Low; Peter Vickerman; Tim Rhodes
Journal:  AIDS Care       Date:  2017-03-10

Review 2.  Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework.

Authors:  Emma Day; Margaret Hellard; Carla Treloar; Julie Bruneau; Natasha K Martin; Anne Øvrehus; Olav Dalgard; Andrew Lloyd; John Dillon; Matt Hickman; Jude Byrne; Alain Litwin; Mojca Maticic; Philip Bruggmann; Havard Midgard; Brianna Norton; Stacey Trooskin; Jeffrey V Lazarus; Jason Grebely
Journal:  Liver Int       Date:  2018-09-22       Impact factor: 5.828

3.  "Someone who is in this thing that I am suffering from": The role of peers and other facilitators for task sharing substance use treatment in South African HIV care.

Authors:  Jessica F Magidson; John A Joska; Kristen S Regenauer; Emily Satinsky; Lena S Andersen; C J Seitz-Brown; Christina P C Borba; Steven A Safren; Bronwyn Myers
Journal:  Int J Drug Policy       Date:  2019-05-10

Review 4.  Hepatitis C models of care: approaches to elimination.

Authors:  Mia J Biondi; Jordan J Feld
Journal:  Can Liver J       Date:  2020-06-04

Review 5.  The role of prevention strategies in achieving HCV elimination in Canada: what are the remaining challenges?

Authors:  Stine Bordier Høj; Nanor Minoyan; Andreea Adelina Artenie; Jason Grebely; Julie Bruneau
Journal:  Can Liver J       Date:  2018-07-17

6.  Recommendations for the management of hepatitis C virus infection among people who inject drugs.

Authors:  Jason Grebely; Geert Robaeys; Philip Bruggmann; Alessio Aghemo; Markus Backmund; Julie Bruneau; Jude Byrne; Olav Dalgard; Jordan J Feld; Margaret Hellard; Matthew Hickman; Achim Kautz; Alain Litwin; Andrew R Lloyd; Stefan Mauss; Maria Prins; Tracy Swan; Martin Schaefer; Lynn E Taylor; Gregory J Dore
Journal:  Int J Drug Policy       Date:  2015-07-17

7.  Perceptions of network based recruitment for hepatitis C testing and treatment among persons who inject drugs: a qualitative exploration.

Authors:  Kathleen M Ward; Sean D McCormick; Mark Sulkowski; Carl Latkin; Geetanjali Chander; Oluwaseun Falade-Nwulia
Journal:  Int J Drug Policy       Date:  2020-11-04

Review 8.  Effects of consumers and health providers working in partnership on health services planning, delivery and evaluation.

Authors:  Dianne Lowe; Rebecca Ryan; Lina Schonfeld; Bronwen Merner; Louisa Walsh; Lisa Graham-Wisener; Sophie Hill
Journal:  Cochrane Database Syst Rev       Date:  2021-09-15

9.  Network-based recruitment of people who inject drugs for hepatitis C testing and linkage to care.

Authors:  Oluwaseun Falade-Nwulia; Kathleen M Ward; Sean McCormick; Shruti H Mehta; Stephanie R Pitts; Stephanie Katz; Geetanjali Chander; David L Thomas; Mark Sulkowski; Carl A Latkin
Journal:  J Viral Hepat       Date:  2020-03-02       Impact factor: 3.517

Review 10.  Urgent action to fight hepatitis C in people who inject drugs in Europe.

Authors:  John F Dillon; Jeffrey V Lazarus; Homie A Razavi
Journal:  Hepatol Med Policy       Date:  2016-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.